IPO Listed — 28 Nov 2025
Listing Price: ₹730
Sudeep Pharma IPO GMP History | Listing Price ₹730 & Kostak Rate
Sudeep Pharma IPO has been listed on November 28, 2025 at a listing price of ₹730, against the issue price of ₹593 — a gain of ₹137 (+23.1%). The day-wise GMP trend below shows how grey market sentiment evolved from subscription to listing.
Sudeep Pharma IPO raised ₹895 Cr. through its IPO at a price band of ₹563 to ₹593 per share, with a lot size of 25 shares. The IPO was open for subscription from 21 Nov 2025 to 25 Nov 2025.
GMP Trend Chart
Day-wise GMP Trend
| Date | GMP | ↑↓ | % | Kostak | Sub. Sauda |
|---|---|---|---|---|---|
| No GMP history available yet. | |||||
Sudeep Pharma IPO Dates
| Event | Date |
|---|---|
| Open Date | 21 Nov, 2025 |
| Close Date | 25 Nov, 2025 |
| Allotment Date | 26 Nov, 2025 |
| Refund Date | 27 Nov, 2025 |
| Credit to Demat | 27 Aug, 2025 |
| Listing Date | 28 Nov, 2025 |
Sudeep Pharma IPO Actual Listing Price
| Basis | Value |
|---|---|
| Issue Price | ₹593 |
| Actual Listing Price | ₹730 (+23.1%) |
| Listing Gain / Loss | +₹137 per share |
| Listing Date | 28 Nov, 2025 |
Is Sudeep Pharma IPO GMP Reliable?
Grey market premium for Sudeep Pharma IPO should be interpreted with caution. The GMP is an unregulated, unofficial market not governed by SEBI. Here's how to read the current signal:
- Subscription rate matters: A high GMP paired with strong subscription — especially QIB (Qualified Institutional Buyer) oversubscription — is a more reliable bullish signal than GMP alone. Read our in-depth analysis: GMP vs Subscription Data — Which Predicts Listing Gains Better?
- Timing matters: GMP in the first 1–2 days of subscription is less reliable. GMP on the final subscription day and the day before listing tends to be the most accurate predictor.
- Grey market is thin: For smaller IPOs, even a handful of large orders can swing the GMP significantly. Treat low-volume GMP signals with extra caution.
- Cross-check before acting: Review the Sudeep Pharma IPO full review for a fundamentals-based assessment before making any grey market trades.
Sudeep Pharma IPO IPO Kostak Rate Explained
The Kostak rate for Sudeep Pharma IPO was not active during the subscription period, as no grey market premium was established. Kostak is the fixed amount a grey market buyer pays for an IPO application regardless of allotment outcome.
The Subject to Sauda price was not active for this IPO. Subject to Sauda only applies if allotment is confirmed — the buyer pays a premium on top of the issue price per lot allotted.
Grey market trading is unofficial and unregulated by SEBI. Proceed with full awareness of the associated risks.
About Sudeep Pharma IPO
The company primarily manufactures calcium-based and mineral ingredients such as calcium carbonate, calcium citrate, and other specialty compounds widely used in tablets, dietary supplements, and fortified food products. Its business model is largely B2B, supplying to pharmaceutical companies, nutraceutical brands, and global distributors. By focusing on quality certifications, scalable manufacturing, and long-term client relationships, the company aims to sustain growth and expand its footprint in regulated and semi-regulated markets worldwide.
Frequently Asked Questions about Sudeep Pharma IPO
What is the GMP of Sudeep Pharma IPO?
The current Grey Market Premium (GMP) of Sudeep Pharma IPO is not yet started or active in the market.
What is the Kostak Price of Sudeep Pharma IPO?
Kostak rate is the profit made by selling an IPO application before allotment. The current Kostak rate for Sudeep Pharma IPO is currently not available.
What is the Subject to Sauda Price of Sudeep Pharma IPO?
Subject to Sauda is the premium amount decided if the allotment is confirmed. The current Subject to Sauda rate is currently not available.
What was the actual listing price of Sudeep Pharma IPO?
Sudeep Pharma IPO listed on November 28, 2025 at ₹730, against the issue price of ₹593 — a gain of +23.1%.
How did the GMP of Sudeep Pharma IPO trend before listing?
The GMP of Sudeep Pharma IPO was stable in its final days before listing. View the day-wise table above for the complete GMP history.
Explore Sudeep Pharma IPO Further
For a complete picture before making your investment decision, explore these resources:
Discussion 0
No comments yet
Be the first to share your thoughts!